Overview

Iressa Follow-up Trial

Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the long-term safety profile and the secondary objective to estimate clinical benefit of ZD1839 (gefitinib).
Phase:
Phase 3
Details
Lead Sponsor:
AstraZeneca
Treatments:
Gefitinib